# Rossari Biotech (NSE: ROSSARI) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ROSSARI · Pivot · prices to 22 Oct 2026

Rossari Biotech (NSE: ROSSARI) closed at ₹421.35 on 22 Oct 2026, up 1.29% on the day. With a market capitalisation of ₹2,334 Cr, it ranks 1083rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.

At its last close the stock traded at 15.7× trailing earnings, against a return on equity of 11.2% in FY26. Over the past year the share price has fallen 34.6%. Its 52-week range is ₹375.00 (30 Mar 2026) to ₹663.00 (28 Oct 2025); the last close is 36.4% below the high. Promoters held 68.14% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹421.35 |
| Market cap | ₹2,334 Cr |
| P/E (trailing) | 15.7 |
| ROE | 11.2% (FY26) |
| ROCE | 15.3% (FY26) |
| Debt to equity | 0.31 |
| 52-week high | ₹663.00 (28 Oct 2025) |
| 52-week low | ₹375.00 (30 Mar 2026) |
| 1-year return | −34.6% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹2,396 Cr | ₹147 Cr |
| FY25 | ₹2,080 Cr | ₹135 Cr |
| FY24 | ₹1,831 Cr | ₹131 Cr |
| FY23 | ₹1,656 Cr | ₹106 Cr |
| FY22 | ₹1,483 Cr | ₹96 Cr |
| FY21 | ₹709 Cr | ₹80 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 68.14%
- Foreign institutions: 2.02%
- Domestic institutions: 14.64%
- Non-institutions: 15.20%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Bhagiradha Chemicals & Industries](https://app.pivotnow.in/stock/BHAGCHEM) | ₹203.99 | ₹2,645 Cr | 187.1 | — |
| [Sirca Paints India](https://app.pivotnow.in/stock/SIRCA) | ₹429.35 | ₹2,438 Cr | 36.9 | — |
| [J.G.Chemicals](https://app.pivotnow.in/stock/JGCHEM) | ₹600.70 | ₹2,354 Cr | 35.8 | — |
| [Stallion India Fluorochemicals](https://app.pivotnow.in/stock/STALLION) | ₹192.50 | ₹2,235 Cr | 36 | — |
| [GSP Crop Science](https://app.pivotnow.in/stock/GSPCROP) | ₹455.15 | ₹2,117 Cr | 18.2 | — |
| [India Glycols](https://app.pivotnow.in/stock/INDIAGLYCO) | ₹305.55 | ₹2,048 Cr | 6.6 | — |

## Questions and answers

### What is the share price of Rossari Biotech today?

Rossari Biotech (NSE: ROSSARI) last closed at ₹421.35 on 22 Oct 2026. Its 52-week high is ₹663.00 and its 52-week low is ₹375.00.

### What is the market cap of Rossari Biotech?

Rossari Biotech's market capitalisation is ₹2,334 Cr (₹2,334 Cr) at the 22 Oct 2026 close, ranking 1083rd among the NSE companies Pivot tracks.

### What is the P/E ratio of Rossari Biotech?

Rossari Biotech trades at a trailing P/E of 15.7. The median P/E of the 6 closest Chemicals peers by market cap is 36.

### What is the ROE and ROCE of Rossari Biotech?

Return on equity was 11.2% in FY26 and return on capital employed was 15.3% in FY26 (consolidated figures).

### Is Rossari Biotech a debt-free company?

No. Rossari Biotech's debt-to-equity ratio was 0.31 in FY26, with total debt of ₹94 Cr.

### How has Rossari Biotech stock performed over the last year?

Rossari Biotech's share price has fallen 34.6% over the past year, −15.2% over three months and −4.8% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Rossari Biotech?

As of 30 Jun 2026: promoters 68.14%, foreign institutions 2.02%, domestic institutions 14.64%, non-institutions 15.20%.

### Who are Rossari Biotech's competitors?

The listed Chemicals companies closest to Rossari Biotech by market cap are Bhagiradha Chemicals & Industries, Sirca Paints India, J.G.Chemicals, Stallion India Fluorochemicals, GSP Crop Science and India Glycols.

### Is Rossari Biotech a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Rossari Biotech's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ROSSARI against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.